Abstract:For the past 10 years we have been investigating the differential effects of genetic diversity on AIDS pathogenesis and HIV infection. In particular, we are interested in two highly polymorphic immunogenetic systems, namely human leukocyte antigen (HLA) and killer immunoglobulin-like receptor (KIR). The allelic polymorphism of HLA genes and chromosomal organization of KIR genes were characterized in multiple AIDS cohorts to examine their effects on AIDS progression and HIV-1 infection. HLA zygosity and three HLA-B alleles show a consistent association with AIDS: HLA-B*35Px shows a susceptible effect associated with a more rapid progression to AIDS, whereas HLA-B*27, B*57 and HLA heterozygosity show protective effects associated with a slower disease progression. Most immunogenetic effects are detected at the stage of CD4 T-cell depletion, but the B27 protection is most significant in the later stages of AIDS-defining illness. The same three HLA alleles are also associated with different risks for HIV transmission: hemophiliac patients with B*35Px were more likely to transmit HIV-1 to their female partners whereas patients with B*27 and B*57 were less likely to transmit the virus. The protective HLA alleles also correlate with a lower level of HIV viral loads compared to the susceptible alleles. Therefore, one mechanism to explain the observed HLA associations with AIDS is their influence on viral load control. The newly described KIR system is an important component of the innate immune mechanism. These polymorphic receptors regulate NK killing of abnormal cells through recognition of class I HLA expression. Therefore KIR may be involved in many of the diseases for which an HLA influence has been identified. Genetic epistasis between two functionally-relevant immunogenetic systems was observed: the combination of KIR3DS1 and its putative ligand HLA-Bw480I show a significant protection for AIDS progression, but either alone has no effect. Our results demonstrate that genetic polymorphisms of both acquired and innate immune systems influence AIDS pathogenesis and the disease progression. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

KIR/HLA Pleiotropism: Protection Against Both HIV and Opportunistic Infections

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

125 Immunogenetic polymorphisms and their effects on AIDS progression:

Epistatic Interaction Between KIR3DS1 and HLA-B Delays the Progression to AIDS

Killer Cell Immunoglobulin–like Receptor 3DL1 Variation Modifies HLA-B*57 Protection Against HIV-1

Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules

HIV-1 Induced Changes in HLA-C∗03 : 04-Presented Peptide Repertoires Lead to Reduced Engagement of Inhibitory Natural Killer Cell Receptors

HLA and AIDS: a Cautionary Tale.

KIR/HLA Compound Genotypes Determine Early Antiviral Response of Natural Killer Cells (35.17)

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

Impact of HLA class I functional divergence on HIV control

Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C

Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

HLA-B Alleles Associate Consistently with HIV Heterosexual Transmission, Viral Load, and Progression to AIDS, but Not Susceptibility to Infection

Aids Restriction Hla Allotypes Target Distinct Intervals of Hiv-1 Pathogenesis

Impact of HLA allele-KIR partners on sexually transmitted HIV-1 infection

Risk Of Classic Kaposi Sarcoma With Combinations Of Killer Immunoglobulin-Like Receptor And Human Leukocyte Antigen Loci: A Population-Based Case-Control Study

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection

Deep analysis of the Major Histocompatibility Complex associations using covariate analysis and haploblocks unravels new mechanisms for the molecular etiology of Elite Control in AIDS

The deleterious effect of the HLA-C1/KIR2DL3 receptor-ligand combination in Chinese HIV patients